North Point Portfolio Managers Corp OH Sells 86 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

North Point Portfolio Managers Corp OH reduced its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 0.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,180 shares of the medical instruments supplier’s stock after selling 86 shares during the period. Mettler-Toledo International makes up approximately 2.0% of North Point Portfolio Managers Corp OH’s investment portfolio, making the stock its 27th biggest position. North Point Portfolio Managers Corp OH’s holdings in Mettler-Toledo International were worth $11,233,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in MTD. Pacer Advisors Inc. increased its position in shares of Mettler-Toledo International by 17.7% in the fourth quarter. Pacer Advisors Inc. now owns 4,569 shares of the medical instruments supplier’s stock worth $5,591,000 after purchasing an additional 687 shares during the period. Union Bancaire Privee UBP SA bought a new position in Mettler-Toledo International in the 4th quarter valued at about $1,616,000. Blue Trust Inc. raised its position in shares of Mettler-Toledo International by 70.8% in the 4th quarter. Blue Trust Inc. now owns 41 shares of the medical instruments supplier’s stock valued at $50,000 after buying an additional 17 shares in the last quarter. M3 Advisory Group LLC boosted its position in shares of Mettler-Toledo International by 5.8% during the 4th quarter. M3 Advisory Group LLC now owns 165 shares of the medical instruments supplier’s stock worth $202,000 after acquiring an additional 9 shares in the last quarter. Finally, KFG Wealth Management LLC increased its stake in Mettler-Toledo International by 7.3% in the fourth quarter. KFG Wealth Management LLC now owns 397 shares of the medical instruments supplier’s stock valued at $486,000 after acquiring an additional 27 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Analyst Ratings Changes

MTD has been the topic of a number of research analyst reports. Wells Fargo & Company reduced their target price on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. Robert W. Baird decreased their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research report on Monday, November 11th. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating on the stock. Evercore ISI upgraded shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and upped their price objective for the stock from $1,375.00 to $1,450.00 in a research report on Thursday, January 2nd. Finally, Stifel Nicolaus lowered their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $1,351.25.

Mettler-Toledo International Stock Down 0.3 %

Shares of NYSE:MTD opened at $1,330.84 on Monday. The business has a fifty day simple moving average of $1,250.00 and a 200 day simple moving average of $1,343.64. Mettler-Toledo International Inc. has a 12-month low of $1,133.46 and a 12-month high of $1,546.93. The firm has a market cap of $28.08 billion, a P/E ratio of 35.88, a P/E/G ratio of 4.19 and a beta of 1.12.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. The company had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. As a group, equities research analysts expect that Mettler-Toledo International Inc. will post 40.42 EPS for the current year.

Insider Transactions at Mettler-Toledo International

In other news, insider Gerry Keller sold 140 shares of the stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the transaction, the insider now owns 6 shares of the company’s stock, valued at $7,524.54. This represents a 95.89 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the sale, the director now directly owns 240 shares of the company’s stock, valued at $314,820. The trade was a 24.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.